This happens in the kidneys, liver and brain
Most professional organizations and regulatory bodies recommend against GLP-1 use during breastfeeding, not because of proven danger, but because of insufficient data to confirm safety definitively
Exenatide- Long-Acting Agents Later, an extended-release formulation of exenatide was developed and given once a week
Ilyas, Z., Perna, S., Al-Thawadi, S., Alalwan, T.A., Riva, A., Petrangolini, G., Gasparri, C., Infantino, V., Peroni, G
Large real-world studies are useful, but they cant rule out crucial confounding factors
Thats the real story behind every flashy peptide trend, melanotan included: not a system thats too slow to catch up, but trust that has already relocated somewhere institutions were never built to watch